Annual Total Liabilities
$87.48 M
+$23.96 M+37.72%
December 31, 2023
Summary
- As of February 8, 2025, KNSA annual total liabilities is $87.48 million, with the most recent change of +$23.96 million (+37.72%) on December 31, 2023.
- During the last 3 years, KNSA annual total liabilities has risen by +$49.95 million (+133.11%).
- KNSA annual total liabilities is now -36.24% below its all-time high of $137.20 million, reached on December 31, 2017.
Performance
KNSA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$118.29 M
+$10.96 M+10.21%
September 30, 2024
Summary
- As of February 8, 2025, KNSA quarterly total liabilities is $118.29 million, with the most recent change of +$10.96 million (+10.21%) on September 30, 2024.
- Over the past year, KNSA quarterly total liabilities has increased by +$40.36 million (+51.78%).
- KNSA quarterly total liabilities is now -13.78% below its all-time high of $137.20 million, reached on December 31, 2017.
Performance
KNSA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
KNSA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.7% | +51.8% |
| 3 y3 years | +133.1% | +204.8% |
| 5 y5 years | +104.9% | +295.7% |
KNSA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.2% | at high | +147.7% |
| 5 y | 5-year | at high | +200.5% | at high | +483.5% |
| alltime | all time | -36.2% | +200.5% | -13.8% | +513.0% |
Kiniksa Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $118.29 M(+10.2%) |
| Jun 2024 | - | $107.33 M(+22.3%) |
| Mar 2024 | - | $87.78 M(+0.3%) |
| Dec 2023 | $87.48 M(+37.7%) | $87.48 M(+12.2%) |
| Sep 2023 | - | $77.94 M(+7.2%) |
| Jun 2023 | - | $72.68 M(+37.7%) |
| Mar 2023 | - | $52.77 M(-16.9%) |
| Dec 2022 | $63.52 M(+33.0%) | $63.52 M(-16.4%) |
| Sep 2022 | - | $75.94 M(+33.0%) |
| Jun 2022 | - | $57.08 M(-11.8%) |
| Mar 2022 | - | $64.72 M(+35.5%) |
| Dec 2021 | $47.76 M | $47.76 M(+23.1%) |
| Sep 2021 | - | $38.81 M(-10.6%) |
| Jun 2021 | - | $43.42 M(+7.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $40.46 M(+7.8%) |
| Dec 2020 | $37.53 M(+28.9%) | $37.53 M(+44.9%) |
| Sep 2020 | - | $25.90 M(+23.2%) |
| Jun 2020 | - | $21.02 M(+3.7%) |
| Mar 2020 | - | $20.27 M(-30.4%) |
| Dec 2019 | $29.11 M(-31.8%) | $29.11 M(-2.6%) |
| Sep 2019 | - | $29.89 M(-9.2%) |
| Jun 2019 | - | $32.94 M(-16.9%) |
| Mar 2019 | - | $39.64 M(-7.2%) |
| Dec 2018 | $42.70 M(-68.9%) | $42.70 M(+51.5%) |
| Sep 2018 | - | $28.19 M(+20.8%) |
| Jun 2018 | - | $23.33 M(+20.9%) |
| Mar 2018 | - | $19.30 M(-85.9%) |
| Dec 2017 | $137.20 M(+66.9%) | $137.20 M |
| Dec 2016 | $82.20 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual total liabilities year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly total liabilities year-on-year change?
What is Kiniksa Pharmaceuticals annual total liabilities?
The current annual total liabilities of KNSA is $87.48 M
What is the all time high annual total liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual total liabilities is $137.20 M
What is Kiniksa Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, KNSA annual total liabilities has changed by +$23.96 M (+37.72%)
What is Kiniksa Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of KNSA is $118.29 M
What is the all time high quarterly total liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly total liabilities is $137.20 M
What is Kiniksa Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, KNSA quarterly total liabilities has changed by +$40.36 M (+51.78%)